LWAM
CRL icon

Legacy Wealth Asset Management’s Charles River Laboratories CRL Stock Holding History

Legacy Wealth Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,437
Closed -$931K – 342
2024
Q1 		$931K Buy
3,437
+24
+0.7% +$5.73K 0.26% 109
2023
Q4 		$807K Buy
3,413
+19
+0.6% +$3.74K 0.26% 109
2023
Q3 		$665K Buy
3,394
+36
+1% +$7.39K 0.24% 128
2023
Q2 		$706K Buy
3,358
+209
+7% +$41.6K 0.25% 126
2023
Q1 		$636K Buy
3,149
+591
+23% +$134K 0.23% 147
2022
Q4 		$557K Buy
2,558
+342
+15% +$74.7K 0.21% 161
2022
Q3 		$436K Buy
2,216
+999
+82% +$216K 0.19% 184
2022
Q2 		$260K Buy
1,217
+81
+7% +$19.8K 0.11% 251
2022
Q1 		$323K Buy
1,136
+40
+4% +$12.3K 0.12% 242
2021
Q4 		$413K Sell
1,096
-90
-8% -$35K 0.14% 221
2021
Q3 		$489K Sell
1,186
-26
-2% -$10.8K 0.22% 174
2021
Q2 		$448K Sell
1,212
-189
-13% -$63.1K 0.2% 188
2021
Q1 		$406K Sell
1,401
-7
-0.5% -$1.95K 0.19% 202
2020
Q4 		$352K Buy
+1,408
New +$335K 0.18% 212

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Legacy Wealth Asset Management's CRL Position: Q2 2024 in Review

Legacy Wealth Asset Management sold out of Charles River Laboratories (CRL) in Q2 2024, closing a stake of 3,437 shares — an estimated $931K sold.

Legacy Wealth Asset Management first reported a position in CRL in Q4 2020 and held it in 14 quarters. The position peaked at $931K in Q1 2024. 665 funds tracked by Wall St. Rank hold CRL as of Q2 2024.

  • Legacy Wealth Asset Management reported no remaining Charles River Laboratories position as of Q2 2024 after selling out during the quarter.
  • Legacy Wealth Asset Management sold 3,437 Charles River Laboratories shares in Q2 2024, an estimated $931K.
  • Legacy Wealth Asset Management first reported a position in Charles River Laboratories in Q4 2020 and held it in 14 quarters.
  • Legacy Wealth Asset Management's Charles River Laboratories position peaked at $931K in Q1 2024.
  • 665 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2024.

Based on Legacy Wealth Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.